| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.007 |